Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial.
Saved in:
| Title: | Efficacy and safety of JMT103 in patients with bone metastases from solid tumors: A randomized Phase Ib clinical trial. |
|---|---|
| Authors: | Ran R; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital and Institute, Beijing, China., Li H; Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China., Sun T; Cancer Hospital of Dalian University of Technology, Liaoning Cancer Hospital and Institute, Shenyang, China., Zhou H; Department of Surgical Oncology, The First Affiliated Hospital of Bengbu Medical University, Bengbu, China., Zang A; Department of Medical Oncology, Affiliated Hospital of Hebei University, Baoding, China., Guo H; Department of Urology, Nanjing Drum Tower Hospital, Affiliated Hospital of Nanjing University Medical School, Nanjing, China.; Institute of Urology, Nanjing University, Nanjing, China., Xie H; Department of Oncology, Xuancheng People's Hospital, Affiliated Xuancheng Hospital of Wannan Medical College, Xuancheng, China., Wu S; Department of Medical Oncology, Peking University First Hospital, Beijing, China., Yan Y; Department of Urology, Beijing Shijitan Hospital, Beijing, China., Yin X; Department of Medical Oncology, Handan First Hospital, Handan, China., Xiong H; Department of Medical Oncology, Huizhou Central People's Hospital, Huizhou, China., Li H; CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Shijiazhuang, China., Yuan J; CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Shijiazhuang, China., Wang J; CSPC ZhongQi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., Shijiazhuang, China., Li H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Breast Oncology, Peking University Cancer Hospital and Institute, Beijing, China., Li J; Department of Medical Oncology, Shanghai East Hospital of Tongji University, Shanghai, China. |
| Source: | International journal of cancer [Int J Cancer] 2025 Jun 01; Vol. 156 (11), pp. 2178-2187. Date of Electronic Publication: 2025 Jan 23. |
| Publication Type: | Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1097-0215 |
|---|---|
| DOI: | 10.1002/ijc.35343 |
